| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
23,910,000 |
| Market
Cap: |
2.46(B) |
| Last
Volume: |
137,872 |
Avg
Vol: |
187,214 |
| 52
Week Range: |
$81.08 - $194.07 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 789 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile ICU Medical is an infusion therapy company. Co. has four product lines: Infusion Consumables, which include Clave™ needlefree products, SwabCap and SwabTip disinfecting caps, ClearGuard HD antimicrobial barrier caps for hemodialysis catheters and Tego™ hemodialysis connector used to cap and protect hemodialysis central venous catheter hubs; Infusion Systems, which provide infusion pumps, dedicated IV sets, software and other services; IV Solutions, which provide a supply of IV solutions, irrigation and nutritionals; and Critical Care, which helps clinicians get real-time access to patients' hemodynamic and cardiac status with a portfolio of monitoring systems and sensors and catheters.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
1,734,283 |
1,736,012 |
1,803,056 |
1,805,820 |
| Total Sell Value |
$183,912,843 |
$184,065,039 |
$196,046,715 |
$196,566,564 |
| Total People Sold |
8 |
8 |
9 |
9 |
| Total Sell Transactions |
14 |
15 |
19 |
23 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Brummett Burcar Alison |
Vice President and Genl Mgr. |
• – – |
2019-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,929 |
11,699 |
|
- |
|
| Lamb Scott E |
Chief Financial Officer, |
• – – |
2019-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,053) |
13,011 |
|
- |
|
| Lamb Scott E |
Chief Financial Officer, |
• – – |
2019-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,226 |
17,064 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2019-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(18,102) |
68,991 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2019-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,509 |
87,093 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2019-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,133) |
8,034 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2019-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,410 |
13,167 |
|
- |
|
| Mcgrody Kevin J |
Controller |
• – – |
2019-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
670 |
3,347 |
|
- |
|
| Mcgrody Kevin J |
Controller |
• – – |
2019-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(232) |
2,677 |
|
- |
|
| Mccall Thomas D |
Vice President and Genl Mgr. |
• – – |
2019-02-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(149) |
2,890 |
|
- |
|
| Mccall Thomas D |
Vice President and Genl Mgr. |
• – – |
2019-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
429 |
3,039 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2019-02-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(236) |
2,163 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2019-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
805 |
2,399 |
|
- |
|
| Lamb Scott E |
Chief Financial Officer, |
• – – |
2019-02-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(348) |
8,838 |
|
- |
|
| Lamb Scott E |
Chief Financial Officer, |
• – – |
2019-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,006 |
9,186 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2019-02-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(348) |
2,757 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2019-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,006 |
3,105 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2019-02-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(688) |
1,594 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2019-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,282 |
2,282 |
|
- |
|
| Mcgrody Kevin J |
Controller |
• – – |
2019-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
290 |
2,909 |
|
- |
|
| Mcgrody Kevin J |
Controller |
• – – |
2019-02-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(119) |
2,619 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2019-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,157 |
2,099 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2019-02-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(425) |
942 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2019-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,759 |
50,584 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2019-02-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,318) |
46,825 |
|
- |
|
839 Records found
|
|
Page 15 of 34 |
|
|
0.50 (0.48%) 
